Article result template
I'm a little template short and blank. I link to void and keep hidden out.
2024-12-19T09:53:18+0000
CFDs are leveraged products. CFD trading may not be suitable for everyone and can result in losses that exceed your deposits, so please ensure that you fully understand the risks involved. CFDs are leveraged products. CFD trading may not be suitable for everyone and can result in losses that exceed your deposits, so please ensure that you fully understand the risks involved.
I'm a little template short and blank. I link to void and keep hidden out.
2024-12-19T09:53:18+0000
Mineral Resources' stock faces a 50% decline as shareholders express concerns over governance and market challenges.
2024-11-21T03:51:01+0000
Arcadium reports a revenue dip to $255 million due to soft lithium demand, while Neuron Pharmaceuticals enjoys a royalty boost, signaling mixed market conditions and strategic adaptations in the face of global economic challenges.
2024-08-08T01:40:23+0100
Pilbara Minerals shares have sunk with the lithium price, but CEO Dale Henderson is pressing on with expansion plans. Where next?
2024-02-09T22:02:44+0000
Pilbara Minerals shares have been falling since August as the lithium price sinks below CNY100,000 per ton. Where next?
2023-12-11T16:45:50+0000
Dive into this week's IG Macro Intelligence to uncover the current state of the lithium market and its potential for a significant rebound in 2024 amid oversupply concerns and changing demand dynamics.
2023-12-05T22:06:27+0000
Pilbara Minerals' profit plunged 89% to $257 million as lithium prices tumbled. Revenue dropped 69% to $1.2 billion, and the company secured a $1 billion debt facility.
2024-08-27T06:35:08+0100